MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Symbol
MRVI on Nasdaq
Shares outstanding
143,892,500
Price per share
$3.83
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
129,342,743
Total reported value
$420,474,500
% of total 13F portfolios
0%
Share change
+1,174,468
Value change
+$4,771,630
Number of holders
157
Price from insider filings
$3.83
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
12 West Capital Management LP 6.2% -25% $34,347,140 -$10,279,500 8,921,335 -23% 12 West Capital Management LP 31 Dec 2025
BlackRock, Inc. 5.9% $24,626,187 8,580,553 BlackRock, Inc. 30 Sep 2025
FELDMAN STUART 5.5% -11% $30,722,238 -$3,702,614 7,979,802 -11% Stuart Feldman 31 Dec 2025
VANGUARD GROUP INC 4.9% -23% $20,450,179 -$6,471,991 7,125,498 -24% The Vanguard Group 30 Sep 2025

As of 31 Dec 2025, 157 institutional investors reported holding 129,342,743 shares of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI). This represents 90% of the company’s total 143,892,500 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
GTCR LLC 14% 20,150,005 0% 11% $65,487,516
BlackRock, Inc. 6.5% 9,378,461 +3% 0% $30,479,999
12 West Capital Management LP 6.2% 8,921,335 -29% 3.5% $28,994,339
BRAIDWELL LP 5.8% 8,353,287 0% 0.87% $27,148,183
VANGUARD GROUP INC 5% 7,166,528 +0.58% 0% $23,291,216
T. Rowe Price Investment Management, Inc. 4.4% 6,336,680 +2.9% 0.01% $20,595,000
MACKENZIE FINANCIAL CORP 4.3% 6,173,656 +1.7% 0.02% $20,148,138
RENAISSANCE TECHNOLOGIES LLC 2.9% 4,225,089 -2.2% 0.02% $13,731,539
Monaco Asset Management SAM 2.4% 3,460,190 -5.4% 3.3% $11,245,618
MORGAN STANLEY 2.4% 3,446,802 +20% 0% $11,202,106
Philosophy Capital Management LLC 2.2% 3,100,322 +20% 1.2% $10,076,046
Tejara Capital Ltd 2.1% 3,020,209 +23% 4.1% $9,815,679
GEODE CAPITAL MANAGEMENT, LLC 2% 2,848,105 +1.2% 0% $9,258,872
Point72 Asset Management, L.P. 2% 2,847,799 +8598% 0.01% $9,255,347
STATE STREET CORP 1.7% 2,414,249 +1.1% 0% $7,846,309
WELLINGTON MANAGEMENT GROUP LLP 1.6% 2,360,059 0% $7,670,192
MIRABELLA FINANCIAL SERVICES LLP 1.5% 2,110,545 -44% 0.66% $6,859,271
GOLDMAN SACHS GROUP INC 1.4% 2,014,214 +28% 0% $6,546,196
MARSHALL WACE, LLP 1.4% 2,000,278 +52% 0.01% $6,500,907
First Eagle Investment Management, LLC 1.3% 1,799,336 +299% 0.01% $5,847,842
MILLENNIUM MANAGEMENT LLC 1.2% 1,797,052 +309% 0% $5,840,419
ROYCE & ASSOCIATES LP 1.2% 1,706,149 -3.2% 0.06% $5,544,984
GENERAL AMERICAN INVESTORS CO INC 1.1% 1,585,316 +1062% 0.32% $5,152,277
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.1% 1,520,320 -0.16% 0.12% $4,941,043
JANE STREET GROUP, LLC 0.9% 1,295,058 +134% 0% $4,208,938

Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 129,342,743 $420,474,500 +$4,771,630 $3.25 157
2025 Q3 130,724,305 $375,089,033 +$4,402,618 $2.87 159
2025 Q2 129,598,496 $312,340,233 +$3,793,871 $2.41 147
2025 Q1 128,634,753 $283,834,872 -$82,865,013 $2.21 183
2024 Q4 140,252,887 $764,374,709 -$46,151,015 $5.45 182
2024 Q3 144,110,886 $1,197,438,577 -$27,583,377 $8.31 215
2024 Q2 147,440,029 $1,055,654,058 +$78,068,119 $7.16 198
2024 Q1 135,404,635 $1,173,684,706 +$20,317,754 $8.67 206
2023 Q4 134,894,754 $883,700,111 -$25,917,156 $6.55 221
2023 Q3 134,929,967 $1,348,336,074 +$67,043,720 $10.00 203
2023 Q2 126,856,268 $1,579,633,607 -$25,271,746 $12.43 219
2023 Q1 128,028,486 $1,792,250,091 +$17,285,470 $14.01 212
2022 Q4 126,849,451 $1,815,086,799 -$138,332,317 $14.31 204
2022 Q3 130,624,782 $3,334,853,905 -$30,836,051 $25.53 187
2022 Q2 131,159,603 $3,725,256,530 +$80,175,272 $28.41 202
2022 Q1 127,945,487 $4,513,679,113 -$18,120,700 $35.27 228
2021 Q4 128,005,395 $5,362,211,646 -$44,041,018 $41.90 218
2021 Q3 127,728,317 $6,268,584,283 +$685,121,082 $49.08 222
2021 Q2 114,346,717 $4,771,851,383 +$738,199,053 $41.73 194
2021 Q1 98,357,799 $3,505,428,822 +$130,695,469 $35.64 141
2020 Q4 97,446,629 $2,733,247,028 +$1,943,879,029 $28.05 114